Dr. Anna Falabella, MD

Dr. Falabella practices at Dermatology Group of Florida, P.A. in South Miami, Florida.

Dr. Falabella's NPI, 1700873734, was assigned on October 4, 2005. Dr. Falabella graduated from Universidad del Valle Health Sciences in 1988. Dr. Falabella holds Florida license ME75028.

Dr. Falabella's primary practice is Dermatology Group of Florida, P.A., at 7800 Sw 57th Ave, South Miami, FL 33143 in Miami-Dade County. The practice phone is (954) 807-9332.

Dr. Falabella's primary practice is Dermatology Group of Florida, P.A. in South Miami, Florida. The medical group on file is Dermatology Group of Florida. Dmand AI also links Dr. Falabella to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Falabella practices. Vendor and product names are available with a free account.

Dermatology is Dr. Falabella's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Falabella is board certified in dermatology by the American Board of Dermatology. Dr. Falabella is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, hives, itchy rashes and joint cyst among the conditions Dr. Falabella treats.

CMS data shows 3,108 Medicare services from Dr. Falabella across 14 procedure codes in 2024, for 423 Medicare patients. Medicare paid $127,383 for them. Every service was in an office.

CMS counts 423 Medicare patients who saw Dr. Falabella in 2024. The largest group is 65 to 74, with 240 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Falabella's median patient age at 52, with 65% women.

In 2024, Dr. Falabella wrote 856 Medicare Part D claims for 298 patients. 92% of them were for generic drugs. CMS names the drug for 745 of them, across 18 drugs with 11 or more claims each, at $41,334 in total drug cost. In 2023, CMS named 580 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Falabella for performance year 2024, reported individually. Dr. Falabella accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,154 procedures of removal of skin lesions by Dr. Falabella, more than 94% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Falabella. The most frequent topics are Wound Healing, Collagen and Skin, Artificial. Dr. Falabella has published most often in Arch Dermatol. Dr. Falabella's most frequent co-authors are Lawrence A. Schachner, MD, Ysabel M. Bello, MD and Robert S. Kirsner, MD.

Dmand AI links Dr. Falabella to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. Open Payments lists research payments to Dr. Falabella that name 1 trial.

CMS Open Payments shows 1,753 general payments to Dr. Falabella from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $2,499. It also lists 4 research payments totaling $4,220 from 2016 to 2020, naming 1 clinical trial.

Dr. Falabella graduated from Universidad del Valle Health Sciences in 1988.

Dr. Falabella is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.